Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

Brett S Carver^{1

2}, Jennifer Tran¹, Anuradha Gopalan³, Zhenbang Chen^{1

4}, Safa Shaikh², Arkaitz Carracedo^{1

4}, Andrea Alimonti^{1

4}, Caterina Nardella^{1

4}, Shohreh Varmeh^{1

4}, Peter T Scardino², Carlos Cordon-Cardo⁵, William Gerald³, Pier Paolo Pandolfi^{6

7

8}

Affiliations

¹ Cancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
² Department of Surgery, Division of Urology, New York, New York, USA.
³ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
⁴ Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Harvard Medical School, Boston, Massachusetts, USA.
⁵ Department of Pathology, Columbia University, New York, New York, USA.
⁶ Cancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA. ppandolf@bidmc.harvard.edu.
⁷ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. ppandolf@bidmc.harvard.edu.
⁸ Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Harvard Medical School, Boston, Massachusetts, USA. ppandolf@bidmc.harvard.edu.

Published Erratum

Brett S Carver et al. Nat Genet. 2020 Sep.

. 2020 Sep;52(9):984.

doi: 10.1038/s41588-020-0688-0.

¹ Cancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
² Department of Surgery, Division of Urology, New York, New York, USA.
³ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
⁴ Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Harvard Medical School, Boston, Massachusetts, USA.
⁵ Department of Pathology, Columbia University, New York, New York, USA.
⁶ Cancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA. ppandolf@bidmc.harvard.edu.
⁷ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. ppandolf@bidmc.harvard.edu.
⁸ Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Harvard Medical School, Boston, Massachusetts, USA. ppandolf@bidmc.harvard.edu.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A, Nardella C, Varmeh S, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP. Carver BS, et al. Nat Genet. 2009 May;41(5):619-24. doi: 10.1038/ng.370. Epub 2009 Apr 26. Nat Genet. 2009. PMID: 19396168 Free PMC article.